Description

oxycodone RP 30mg

Oxycodone RP 30mg refers to a 30mg dose of the prescription opioid medication Roxicodone, also known as oxycodone hydrochloride. This is a powerful painkiller, but it also has a high potential for abuse and addiction and is classified as a Schedule 2 drug. The “RP” in this context is likely a reference to “Roxicodone,” a brand name for the medication.

Oxycodone is an opioid painkiller. It’s use to treat severe pain, for example after an operation or a serious injury, or pain from cancer. Sometimes it’s also use for other types of long-term pain when other painkillers. Such as paracetamol, ibuprofen and aspirin, have not work.

Management of Overdose

When a person overdoses on oxycodone, an opioid antagonist such as naloxone should be administer. Clinicians should not give opioid antagonists such as naloxone in the absence of clinically significant respiratory or circulatory depression. Repeat dosing may be necessary as the duration of action of these drugs can vary from 30 to 120 minutes. The FDA has recently approve a 4 mg naloxone hydrochloride nasal spray for over-the-counter usage, the first naloxone product sanctioned for nonprescription use.

Warnings and Precautions

Oxycodone therapy is contraindicated in patients with respiratory depression, acute bronchospasm, hypercarbia, hypersensitivity to oxycodone, and known or suspected ileus or gastrointestinal obstruction.

If limited information exists involving studies of allergenic cross-reactivity in opioid medications, the possibility of cross-sensitivity cannot be fully excluded. For patients with an opioid allergy, a clear description of the allergic reaction should be explore and documented adequately before considering oxycodone.

Oxycodone Dosage

Single-entity CR oxycodone or IR oxycodone were substituted for 6–12 tablets or capsules of fixed-combination analgesics per day containing 30—60 mg of oxycodone or its equivalent plus acetaminophen. The majority of patients (79%) had received six to nine tablets or capsules per day. In 71% of patients, the prestudy combination analgesic was oxycodone/acetaminophen.